Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study

Bibiana Chazan1,2, Raul Raz1,2, Hana Edelstein1

  • 11 Infectious Diseases Unit, Emek Medical Center , Afula, Israel .

Microbial Drug Resistance (Larchmont, N.Y.)
|October 3, 2015
PubMed
Abstract

Insights

Group A Streptococcus (GAS) remains highly susceptible to common antibiotics like penicillin and macrolides in northern Israel. Continued monitoring and judicious antimicrobial use are crucial to preserve this high susceptibility.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Rising antimicrobial resistance poses a global health threat, complicating patient treatment.
  • Misuse of antibiotics accelerates pathogen resistance, limiting therapeutic options.
  • Monitoring antibiotic resistance in Streptococcus pyogenes (Group A Streptococcus-GAS) is vital for treating acute tonsillitis.

Purpose of the Study:

  • To evaluate the susceptibility of GAS to penicillin, macrolides, clindamycin, and tetracycline in northern Israel.
  • To compare current GAS susceptibility rates with historical data from 2004 and other regions.

Main Methods:

  • Cultured throat samples from 300 outpatients between September and October 2011.
  • Conducted susceptibility testing at the Emek Medical Center regional laboratory.

Main Results:

  • GAS isolates in northern Israel demonstrated very high susceptibility rates to penicillin, erythromycin, azithromycin, clindamycin, and tetracycline.
  • Findings indicate sustained high antimicrobial susceptibility in GAS in the region.

Conclusions:

  • Maintaining high GAS susceptibility requires ongoing antimicrobial stewardship and surveillance.
  • Educational programs and targeted treatment protocols are recommended to preserve antibiotic effectiveness.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
107
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
70
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.5K